CalciMedica, Inc. (CALC)Healthcare | Biotechnology | La Jolla, United States | NasdaqCM
0.60 USD
-0.01
(-0.902%) ⇩
(April 17, 2026, 2:28 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:31 p.m. EDT
CALC is currently in a highly volatile and uncertain environment, with a significant drop in price over the past few weeks. The stock is trading well below its 52-week low, and the fundamental data suggests a lack of profitability and weak financial health. While the options market shows some signs of potential upward movement, the overall outlook for short-term and long-term investment is bleak. The stock lacks a consistent dividend history and has a high overall risk profile. Investors should exercise caution and consider the potential for further declines before making any investment decisions. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 2.064307 |
| AutoETS | 2.068814 |
| MSTL | 2.081964 |
| AutoTheta | 2.282257 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 49% |
| H-stat | 1.11 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 3.58 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 9,517,197 |
| Forward P/E | -0.37 |
| Beta | 1.09 |
| Website | https://calcimedica.com |
As of April 11, 2026, 1:31 p.m. EDT: The options activity indicates a mixed sentiment. For the April 17 expiration, there is significant call volume and open interest at the $1.0 strike, suggesting some bullish sentiment, though it's far from the current price. The July 17 expiration shows higher volatility with significant call volume at the $7.0 and $10.0 strikes, indicating potential for a substantial price move upwards. Puts show limited activity, but there is some bearish positioning at the $2.0 and $4.0 strikes, suggesting caution. Overall, the options market appears to be anticipating a potential upward move, but with considerable uncertainty.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.60568845 |
| Address1 | 505 Coast Boulevard South |
| Address2 | Suite 307 |
| All Time High | 8.59 |
| All Time Low | 0.461 |
| Ask | 0.6508 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 266,100 |
| Average Daily Volume3 Month | 1,278,963 |
| Average Volume | 1,278,963 |
| Average Volume10Days | 266,100 |
| Beta | 1.088 |
| Bid | 0.6131 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | -0.43 |
| City | La Jolla |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.6045 |
| Current Ratio | 3.577 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.6282 |
| Day Low | 0.6001 |
| Display Name | CalciMedica |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -23,075,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.272 |
| Enterprise Value | 6,287,789 |
| Eps Forward | -1.63 |
| Eps Trailing Twelve Months | -1.97 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.63606 |
| Fifty Day Average Change | -0.031560004 |
| Fifty Day Average Change Percent | -0.049617965 |
| Fifty Two Week Change Percent | -60.568844 |
| Fifty Two Week High | 7.2 |
| Fifty Two Week High Change | -6.5955 |
| Fifty Two Week High Change Percent | -0.9160417 |
| Fifty Two Week Low | 0.461 |
| Fifty Two Week Low Change | 0.1435 |
| Fifty Two Week Low Change Percent | 0.31127983 |
| Fifty Two Week Range | 0.461 - 7.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,686,749,400,000 |
| Float Shares | 9,003,316 |
| Forward Eps | -1.63 |
| Forward P E | -0.3708589 |
| Free Cashflow | -13,020,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 16 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.21605 |
| Held Percent Institutions | 0.4348 |
| Implied Shares Outstanding | 15,743,916 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,023-06-14 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California. |
| Long Name | CalciMedica, Inc. |
| Market | us_market |
| Market Cap | 9,517,197 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_34235142 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -29,562,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,603,788 |
| Number Of Analyst Opinions | 3 |
| Open | 0.62 |
| Operating Cashflow | -21,178,000 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 858 952 5500 |
| Previous Close | 0.61 |
| Price Hint | 4 |
| Price To Book | -1.4058139 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.442 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0055000186 |
| Regular Market Change Percent | -0.9016424 |
| Regular Market Day High | 0.6282 |
| Regular Market Day Low | 0.6001 |
| Regular Market Day Range | 0.6001 - 0.6282 |
| Regular Market Open | 0.62 |
| Regular Market Previous Close | 0.61 |
| Regular Market Price | 0.6045 |
| Regular Market Time | 1,776,450,523 |
| Regular Market Volume | 46,424 |
| Return On Assets | -0.8657 |
| Return On Equity | -7.6102505 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 15,743,916 |
| Shares Percent Shares Out | 0.0215 |
| Shares Short | 337,917 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 391,796 |
| Short Name | CalciMedica, Inc. |
| Short Percent Of Float | 0.030299999 |
| Short Ratio | 0.75 |
| Source Interval | 15 |
| State | CA |
| Symbol | CALC |
| Target High Price | 15.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 10.33333 |
| Target Median Price | 10.0 |
| Total Cash | 13,016,000 |
| Total Cash Per Share | 0.827 |
| Total Debt | 9,700,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.97 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.821965 |
| Two Hundred Day Average Change | -2.217465 |
| Two Hundred Day Average Change Percent | -0.7857875 |
| Type Disp | Equity |
| Volume | 46,424 |
| Website | https://calcimedica.com |
| Zip | 92,037 |